Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BioStem Technologies to Present at the Centri Capital Conference
-
BC3 Technologies has received a U.S. patent for its SEAL Hemostatic Wound Spray to stop blood loss fast.
-
BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million Full-Year 2024 Revenue of $301.8 Million
-
RESEARCH TRIANGLE PARK, N.C., April 10, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics has named Roger Ilagan, PhD as its new Chief Scientific Officer (CSO). Responsible for guiding the biologic...
-
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)
-
BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025
-
AVITA Medical announces U.S. launch of Cohealyx™, a collagen-based dermal matrix designed to promote tissue integration and revascularization.
-
BioStem Technologies Announces Extension to File 2024 Annual Report with OTC
-
BioStem Announces Notice of Allowance for Two U.S. Patent Applications
-
BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference